CATIE envisions a future free of HIV and hepatitis C.
CATIE is Canada's source for accessible, evidence-based information about HIV and hepatitis C prevention, testing, care, treatment and support. CATIE strengthens the national response to HIV and hepatitis C by fostering collaboration and capacity among people living with HIV and/or hepatitis C and other affected populations, frontline service providers and researchers to reduce transmission and improve health and well-being.
CATIE is Canada's source for up-to-date, unbiased information about HIV and hepatitis C. We connect people living with HIV or hepatitis C, at-risk communities, healthcare providers and community organizations with the knowledge, resources and expertise to reduce transmission and improve quality of life.
Connect With the Tools You Need
The latest news about HIV and hepatitis C treatment and prevention in clear language
Resources developed in partnership with organizations across Canada
Events for service providers to share approaches and lessons learned
Educational opportunities in person and online
Order a CATIE Brochure
This bilingual brochure provides a brief overview of CATIE's programs and services. Order a copy from the CATIE Ordering Centre.
Read more about CATIE's history and milestones.
CATIE (Canadian AIDS Treatment Information Exchange)
555 Richmond Street West, Suite 505
Toronto, Ontario M5V 3B1 Canada
Categories Covered:Other Populations, Women, HIV Treatment and Medical Care, Nutrition and Fitness, People Over 50, HIV Epidemiology, Adverse Events, Comorbidities, and HIV, HIV and Mental Health Care, HIV Advocates in the Spotlight, Gay Men, Tenofovir Disoproxil Fumarate (Viread), Switching or Stopping HIV Treatment, Managing People Newly Diagnosed With HIV, HIV Care Continuum, HIV in the Arts, Providing Quality HIV Care, U=U (Undetectable Equals Untransmittable, i.e. HIV Treatment as Prevention), HIV Testing, Managing Primary/Acute HIV Infection, HIV Prevention Methods, Living Well With HIV, Lopinavir/Ritonavir (Kaletra), Raltegravir (Isentress), Kidney Issues and HIV, Non-HIV Sexually Transmitted Infections, HIV Treatment Strategies, PrEP (HIV Pre-Exposure Prophylaxis), HIV in Specific Countries, Mental Health, Newly Diagnosed, Relationships and Sex, HIV/AIDS Basics, HIV Education and Risk Management, Body Fat, Lipodystrophy and HIV, HIV, Discrimination, and Law, Finding HIV Support Groups and Services, HIV Treatments in Development, HIV Care and Services Outside the US, History of HIV/AIDS, Starting HIV Treatment and Medical Care, HIV in Film, TV, and Media, Latinx People, HIV Basic Science and Pathogenesis, Cobicistat/Emtricitabine/Elvitegravir/Tenofovir Alafenamide (Genvoya, E/C/F/TAF), Pregnancy, Childbirth, and HIV, Managing Long-Term HIV Survivors, PEP (HIV Post-Exposure Prophylaxis), Rilpivirine (Edurant), Efavirenz (Sustiva, Stocrin), Dental/Mouth Issues and HIV, Physical Health Issues, Dolutegravir (Tivicay), Substance Use and Harm Reduction for HIV, PrEP (HIV Pre-Exposure Prophylaxis), HIV Advocacy and Activism, HIV/AIDS Outside the U.S., HIV Stigma and Discrimination, Bone Problems and HIV, FDA-Approved HIV Medications, Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy, B/F/TAF), HIV Prevention and Transmission, Hormone-Related Issues and HIV, Darunavir (Prezista), People Under 30, HIV Prevention for People With HIV, HIV in Books and Publishing, Viramune (Nevirapine), First-Line HIV Treatment, Meeting the Costs of HIV Care, HIV/AIDS Statistics, Ritonavir (Norvir), Emtricitabine/Tenofovir Alafenamide (Descovy), Heart Disease and HIV, Maraviroc (Selzentry, Celsentri), Neuorlogical (Brain/Nerve) Issues and HIV, Conceiving and Having a Baby, Abacavir (Ziagen), Etravirine (Intelence), Tools and Tips for HIV Advocacy, Spirituality and Religion, HIV Case Management and Social Work, Disclosing Your HIV Status, Managing HIV Drug Resistance, Nevirapine (Viramune), Didanosine (ddI, Videx), Anemia, Fatigue, and HIV, Atazanavir (Reyataz), Enfuvirtide (T-20, Fuzeon), Personal Stories from the HIV Community, Gastrointestinal (Gut) Issues and HIV, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate (Stribild), Managing HIV Drug Resistance, Non-Medical HIV Prevention, Tuberculosis and HIV, Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada), Cobicistat (Tybost), Pediatric HIV Care, Understanding HIV-Related Lab Tests, African-Americans, Saquinavir (Invirase)
Women who experienced food insecurity were more likely to have elevated levels of inflammation. Researchers suspect that food insecurity causes stress, and this stress in turn raises inflammation in HIV-positive women.
In a recent study, older men who engaged in high-intensity aerobic exercise (but not moderate intensity) showed a significantly increased their ability to maximize their use of oxygen.
"At this year's International AIDS Conference ... we witnessed several pivotal developments in the global HIV response," Sean Hosein writes. "We also saw some setbacks in our efforts to prevent infections and improve the lives of people living with H...
When a person taking antiretroviral treatment has an ongoing undetectable viral load and is engaged in care, they do not transmit HIV to their sexual partners. Here is why supporting "undetectable equals untransmittable" is important.
Although most attention is paid to preventing the transmission of HIV to intimate partners, women's sexual concerns go far beyond condom use.
While treatment has advanced in leaps and bounds and HIV has become much more manageable, stigma remains rampant.